# Novomics Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/novomics-co

- Industry: Medical Devices & Equipment
- Headquarters: Seoul, South Korea
- Website: www.novomics.com
- Total disclosed funding: $22M
- Latest round: Series C (Sep 5, 2018)
- Investors on record: 6

## About

Based in Seoul, South Korea, and established in 2010, Novomics Co., Ltd. operates as a developer of molecular diagnostic tests for stage II-III gastric cancer patients. In 2020, it passed China Inspection and Quarantine Certification.

The company has developed a molecular diagnostic assay, the nProfiler 1 Stomach Cancer Assay. It is designed to provide prognostic information to clinicians and help determine treatment plans and methods to avoid over- or under-treatment according to the patient's condition.

## Funding rounds

- Series C, Sep 5, 2018, $13M — G.N.TECH Venture Capital, SV Investment, Stonebridge Ventures
- Series B, Mar 17, 2017, $5.3M — Yuanta Investment, Partners Investment, JB Investment, SV Investment
- Series A, May 9, 2015, $3.7M — Yuanta Investment, Partners Investment, G.N.TECH Venture Capital, JB Investment, SV Investment

## Investors

- Yuanta Investment (https://capitalatlas.ai/funds/yuanta-investment) — Series A, Series B
- Partners Investment (https://capitalatlas.ai/funds/partners-investment) — Series A, Series B
- G.N.TECH Venture Capital (https://capitalatlas.ai/funds/g-n-tech-venture-capital) — Series A, Series C
- JB Investment (https://capitalatlas.ai/funds/jb-investment) — Series A, Series B
- SV Investment (https://capitalatlas.ai/funds/sv-investment) — Series A, Series B, Series C
- Stonebridge Ventures — Series C